HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

question-icon

Request For Second Opinion For Breast Cancer Treatment.

default
Posted on Tue, 12 Jun 2012
Question: 2nd opinion requested for right breast cancer treatment for my mother
doctor
Answered by Dr. J. Krueger (1 hour later)
Hello,

Thank you for the query. I have seen your reports also.

It is good that the breast cancer is detected early. The use of Femara for 5 years and radiation for 5-6 weeks is appropriately recommended. Letrozole is approved treatment for the adjuvant (following surgery) treatment of postmenopausal women with hormone receptor-positive early stage breast cancer. Adjuvant therapy is reportedly introduced to reduce the mortality rates by stopping the micrometastasis of the undetected cancer cells.

You can discuss with the Medical Oncologist if there is a need for Her2neu by FISH method. This method helps to determine if Her2neu is definitively Positive or Negative. If it is positive, the Medical Oncologist will add Herceptin (Trastuzumab) to the current regimen.

From the information you provided, the prognosis for a longer life is good.

Hope I have answered your question.

Dr. Krueger, MD
Note: For further queries related to kidney problems Click here.

Above answer was peer-reviewed by : Dr. Chakravarthy Mazumdar
doctor
Answered by
Dr.
Dr. J. Krueger

Oncologist, Radiation

Practicing since :1989

Answered : 8 Questions

premium_optimized

The User accepted the expert's answer

Share on

Get personalised answers from verified doctor in minutes across 80+ specialties

159 Doctors Online

By proceeding, I accept the Terms and Conditions

HCM Blog Instant Access to Doctors
HCM Blog Questions Answered
HCM Blog Satisfaction
Request For Second Opinion For Breast Cancer Treatment.

Hello,

Thank you for the query. I have seen your reports also.

It is good that the breast cancer is detected early. The use of Femara for 5 years and radiation for 5-6 weeks is appropriately recommended. Letrozole is approved treatment for the adjuvant (following surgery) treatment of postmenopausal women with hormone receptor-positive early stage breast cancer. Adjuvant therapy is reportedly introduced to reduce the mortality rates by stopping the micrometastasis of the undetected cancer cells.

You can discuss with the Medical Oncologist if there is a need for Her2neu by FISH method. This method helps to determine if Her2neu is definitively Positive or Negative. If it is positive, the Medical Oncologist will add Herceptin (Trastuzumab) to the current regimen.

From the information you provided, the prognosis for a longer life is good.

Hope I have answered your question.

Dr. Krueger, MD